← Back to directory

Jean‐Yves Scoazec

Researcher Next ID · RN-032573

Researcher · Biochemistry, Genetics and Molecular Biology

University Health Network

Toronto, France

Accepting doctoral researchersFunding unknown
Works count
1,295
Citation count
34,518
H-index
98
i10-index
424

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Neuroendocrine Tumor Research Advances
Cancer Genomics and Diagnostics
Prostate Cancer Treatment and Research
Fibroblast Growth Factor Research
Pancreatic and Hepatic Oncology Research

Publications

  • Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy

    Cancer Cell · 2022 · https://doi.org/10.1016/j.ccell.2022.01.002

  • Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.01.003

  • A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

    The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30413-3

  • Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma

    Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0217-1

  • A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

    Modern Pathology · 2018 · https://doi.org/10.1038/s41379-018-0110-y

  • High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

    Cancer Discovery · 2017 · https://doi.org/10.1158/2159-8290.cd-16-1396

  • ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours

    Neuroendocrinology · 2017 · https://doi.org/10.1159/000464292

  • ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification

    Neuroendocrinology · 2017 · 10.1159/000457956

  • Ovarian Cancer: A Heterogeneous Disease

    Pathobiology · 2017 · https://doi.org/10.1159/000479006

  • Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation

    Gastroenterology · 2016 · https://doi.org/10.1053/j.gastro.2016.11.042

  • SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

    International Journal of Cancer · 2014 · https://doi.org/10.1002/ijc.28913

  • Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia

    Journal of Hepatology · 2014 · https://doi.org/10.1016/j.jhep.2014.05.023

  • Detection of C3d-Binding Donor-Specific Anti-HLA Antibodies at Diagnosis of Humoral Rejection Predicts Renal Graft Loss

    Journal of the American Society of Nephrology · 2014 · https://doi.org/10.1681/asn.2013101144

  • Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation

    Cancer Cell · 2014 · https://doi.org/10.1016/j.ccr.2014.03.005

  • Are G3 ENETS neuroendocrine neoplasms heterogeneous?

    Endocrine Related Cancer · 2013 · https://doi.org/10.1530/erc-13-0027

  • ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes

    Neuroendocrinology · 2012 · https://doi.org/10.1159/000335591

  • Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

    PLoS ONE · 2011 · 10.1371/journal.pone.0020294

  • BRAFMutation Status in Gastrointestinal Stromal Tumors

    American Journal of Clinical Pathology · 2009 · 10.1309/ajcppckga2qgbj1r

  • Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer

    Proceedings of the National Academy of Sciences · 2008 · 10.1073/pnas.0709810105

  • ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification

    Neuroendocrinology · 2008 · https://doi.org/10.1159/000182196

  • TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

    Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2007 · https://doi.org/10.1007/s00428-007-0452-1

  • Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma

    Neuroendocrinology · 2006 · https://doi.org/10.1159/000098010

  • Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma

    Neuroendocrinology · 2006 · https://doi.org/10.1159/000098012

  • Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

    Hepatology · 2006 · https://doi.org/10.1002/hep.21068

  • Netrin-1 controls colorectal tumorigenesis by regulating apoptosis

    Nature · 2004 · https://doi.org/10.1038/nature02788

  • Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis

    International Journal of Cancer · 2003 · 10.1002/ijc.11254

Current projects

    No projects listed.